Volt - Massachusetts - I am currently looking for an Deputy QA Director in the Paris, France. Please see more below. This opportunity is with a company who are experts in R&D and clinical development of life saving therapeutics. Leading programs in oncology (cell therapy), neurology, gene therapy and inflammatory diseases, with over 13 Phase 3 clinical studies in more than 30 countries. Key Responsibilities: You will have the freedom to promote a quality focused culture that allows continuous improvement across the functional areas of the business. Acting as the Deputy QA Director (Associate Director), you will be tasked on your leadership and guidance duties during EMA and FDA health authorities inspections; training programs, responses to regulatory agencies and ensuring the QA team are well prepared for inspections/audits. Have independence to develop and improve quality management systems for pre-clinical and clinical studies. Recruit, develop and retain QA professionals, building a world class QA team. Must be able to investigate and identify any quality related issues to ensure the correct solution is found. Requirements: Over 7 year's experience in a in quality assurance role with management experience. Background in pharmaceutical company Have experience dealing with EMA and FDA inspections Worked within Biological Sciences or related field with an education or training in cell culture and gene therapy a plus ASQ Auditor certification Apply now... - Permanent - Full-time
source http://jobviewtrack.com/en-in/job-1a1d417c6c442b075511431707136c36240025296b374359584e590b1d6f144c15/d8fba5a76b6baddf4a6a0afa8d71ecc2.html?affid=f584d43114bf1954a48e3ec6be21b6ec
Subscribe to:
Post Comments (Atom)
-
Tough challenges await Rishi Sunak: Tory strategists https://ift.tt/ibXqIld has successfully eaten into the opposition poll lead - Keir Star...
-
Cryptocurrency, or "crypto" or "tokens", is all the rage right now. People are buying and using cryptos for varied purpo...
-
India likely to benefit from slump in Hong Kong market https://ift.tt/yH6rjid Several overseas institutional investors have pruned exposure ...
No comments:
Post a Comment